281 related articles for article (PubMed ID: 17341301)
1. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.
Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301
[TBL] [Abstract][Full Text] [Related]
2. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S
Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
[TBL] [Abstract][Full Text] [Related]
3. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
Downie-Doyle S; Bayat N; Rischmueller M; Lester S
Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism.
Goswami R; Gupta N; Ray D; Rani R; Tomar N; Sarin R; Vupputuri MR
Int J Immunogenet; 2005 Dec; 32(6):393-400. PubMed ID: 16313305
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
[TBL] [Abstract][Full Text] [Related]
6. [Association of CTLA-4 + 49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity].
Jin P; Xiang B; Lin J; Huang G; Zhou WD; Zheng C; Chao C; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1246-9. PubMed ID: 19595177
[TBL] [Abstract][Full Text] [Related]
7. The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland.
Suppiah V; O'Doherty C; Heggarty S; Patterson CC; Rooney M; Vandenbroeck K
Exp Mol Pathol; 2006 Apr; 80(2):141-6. PubMed ID: 16248997
[TBL] [Abstract][Full Text] [Related]
8. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus.
Torres B; Aguilar F; Franco E; Sánchez E; Sánchez-Román J; Jiménez Alonso J; Núñez-Roldán A; Martín J; González-Escribano MF
Arthritis Rheum; 2004 Jul; 50(7):2211-5. PubMed ID: 15248219
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.
Pavlova A; Diaz-Lacava A; Zeitler H; Satoguina J; Niemann B; Krause M; Scharrer I; Hoerauf A; Wienker T; Oldenburg J
Haemophilia; 2008 Mar; 14(2):355-60. PubMed ID: 18081831
[TBL] [Abstract][Full Text] [Related]
10. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.
Suppiah V; Alloza I; Heggarty S; Goris A; Dubois B; Carton H; Vandenbroeck K
J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease.
Dallos T; Avbelj M; Barák L; Zapletalová J; Pribilincová Z; Krajcírová M; Kostálová L; Battelino T; Kovács L
Neuro Endocrinol Lett; 2008 Jun; 29(3):334-40. PubMed ID: 18580850
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
13. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
14. CTLA4 +49 A/G and CT60 polymorphisms in Dutch coeliac disease patients.
van Belzen MJ; Mulder CJ; Zhernakova A; Pearson PL; Houwen RH; Wijmenga C
Eur J Hum Genet; 2004 Sep; 12(9):782-5. PubMed ID: 15199380
[TBL] [Abstract][Full Text] [Related]
15. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease.
Du L; Yang P; Hou S; Zhou H; Kijlstra A
Br J Ophthalmol; 2009 Oct; 93(10):1378-81. PubMed ID: 19570770
[TBL] [Abstract][Full Text] [Related]
16. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.
Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y
Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658
[TBL] [Abstract][Full Text] [Related]
17. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians.
Baniasadi V; Narain N; Goswami R; Das SN
Tissue Antigens; 2006 May; 67(5):383-9. PubMed ID: 16671945
[TBL] [Abstract][Full Text] [Related]
18. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
19. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
20. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.
Barton A; Jury F; Eyre S; Bowes J; Hinks A; Ward D; Worthington J
Arthritis Rheum; 2004 Mar; 50(3):748-52. PubMed ID: 15022315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
